Head & Neck Cancers | Specialty

The OncLive Head and Neck Cancer condition center page is a comprehensive resource for clinical news and expert insights on treatment for patients with head and neck cancer. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research within head and neck cancer.

Dr. Pearlstone on Technological Challenges

March 8th 2011

John Theurer Cancer Center Opens New Comprehensive Facility

March 4th 2011

The John Theurer Cancer Center (JTCC) at Hackensack University Medical Center in New Jersey, one of the largest cancer centers in the United States

Net Guides: Oral Cancer

December 16th 2010

Useful Online Resources and Clinical Trials for Oral Cancer

ASCO 2010: Opaxio Highly Active in Esophageal Cancer

August 14th 2010

A drug that delivers paclitaxel in a novel way has yielded favorable results in a phase II trial of patients with advanced esophageal cancer, prompting the company developing the drug to plan a phase III trial.

ASCO 2010: Vandetanib Extends PFS in Medullary Thyroid Carcinoma

August 14th 2010

Data from the phase III ZETA trial show that vandetanib (Zactima), a selective tyrosine kinase inhibitor, significantly slows the progression of advanced medullary thyroid carcinoma

The RapidReporter: Recent Developments, Findings, and Research in Head and Neck Cancer

July 6th 2010

Identifying head and neck cancer patients who possess the FcyR genotype may help predict whether they will respond to monoclonal antibodies, which work by killing cancer cells bearing epidermal growth factor receptors (EGFR) on their surface.

50th Annual Meeting of the American Society of Hematology

January 27th 2009

Highlights from the 50th Annual Meeting of the American Society of Hematology.